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have a better insight in the mechanism of balloon angioplasty (PTA) of the
superficial femoral artery (SFA). The EPISODE trial (Evaluation Peripheral In-
travascular Sonography on Dotter Effect) is a multicenter study evaluating
whether IVUS is a better predictor of the outcome after PTA of the SFA than
standard angiography. We studied 41 patients (pts) with angiographic suc-
cessful PTA (26 M, 15 F; mean age 70 ± 8 yr). Of each patient, the smallest
free lumen area seen on IVUS before and after PTA was selected. Oualitative
analysis included lesion morphology and geometry before PTA and dissec-
tion, plaque rupture and internal elastic lamina rupture after PTA. Quantitative
analysis included free lumen area (FLAl. free lumen diameter (FLO), media-
bounded area (MBA) and percentage area stenosis (%S) before and after
PTA. Success or failure at 1 month and at 6 months was defined using a
combination of clinical and objective vascular laboratory criteria, including
anklelbrachial index and duplex.
At one month success of PTA was evidenced in 30 pts and failure in 11
pts. After 6 months success was seen in 19 pts (46%; Group I) and failure in
22 pts (54%; Group II). No differences in outcome could be demonstrated on
the basis of qualitative IVUS findings before and after PTA. Quantitative data
before PTA of both groups were not significantly different. After PTA both
groups showed a significant increase in FLA and FLO and a significant de-
crease in %S. Significant differences were encountered between the Group
I and II for FLA (13.0 vs 9.7 mm2 and FLO (4.0 vs 3,5 mml. whereas no sig-
nificant differences were encountered in MBA and %S.
Conclusion: The present study indicates for the first time that the presence
of a narrow free lumen site within the lumen evidenced by IVUS following
PTA is the most common mechanism underlying restenosis. Given the high
incidence of failures seen at 1 month it is likely that rest-stenosis rather than
restenosis may be the underlying mechanism to the failures evidenced.
definitively established. Data was collected from multiple European centers
performing intracoronary ultrasound examinations under the auspices of the
SUbgroup on Intravascular Ultrasound of the Working Group on Echocardiog-
raphy of the European Society of Cardiology. Information was obtained about
the number of exams performed, complications related to imaging. patient's
age and CAD risk factors, indication for exam, concomitant procedures per-
formed, catheter size and location. and any adverse clinical consequences
related to ICUS imaging. Twelve centers (mean 59 patients, range 3-140) sub-
mitted information about their experience with ICUS. A total of eight (1.1 %)
complications were reported in a total of 718 examinations. All complica-
tions occurred during ICUS exams in patients with atherosclerotic coronary
disease with a diagnosis of unstable or stable angina who underwent PTCA.
Four cases of transient vessel spasm were seen, all of which resolved after
administration of nitroglycerin. Two cases of vessel dissection were noted
when imaging after PTCA. and thought to be "possibly" related to the ul-
trasound catheter. Two cases of guidewire entrapment after distal advance-
ment of the transducer were reported. requiring the catheter and guidewire
to be withdrawn. No adverse clinical consequences due to ICUS imaging
were reported. There was no difference in frequency of complications be-
tween centers assessed by Chi square (p = 0.232).
Conclusion: Intracoronary ultrasound examinations can be performed
safely with a very low rate of acute complications.
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Multicenter European Registry
John MeB. Hodgson, Gregg W. Stone, Fred G. SI. Goar. Thomas Linnemeier.
Helen Sheehan, CLOUT investigators. University Hospitals of Cleveland, Cleveland.
OH; EI Camino Hospital, Mt. View, CA
The CLOUT Pilot Study hypothesis is that intracoronary ultrasound (ICUS)
guidance can maximize the potential of balloon angioplasty through the safe
application of carefully chosen oversized balloons. PTCA was performed un-
til success was obtained using standard angiographic criteria. ICUS was then
performed and. based on the degree of reference segment disease, balloons
were upsized from 0.25 to 0.75 mm (mean 0.4 mm) regardless of the angio-
graphic results. There have been no complications using this strategy in the
initial 14 of a planned 100 patients. ICUS measures were performed using
semiautomated programs at a core laboratory.
Results; In the reference segment. ICUS revealed a mean lumen diameter
of 2.60 ± 0.35 mm and plaque thickness of 0.78 ± 0.11 mm; on average
54.75 ± 11.05% of the reference vessel was occupied by atheroma. At ini-
tial ICUS evaluation after angiographically successful PTCA, the lesion had a
minimal lumen diameter (MLD) of 1.78 ± 0.22 mm and lumen area of 3.14 ±
0.88 mm2 Following balloon upsizing, the lesion MLD increased to 1.95 ±
0.15 mm (8.7% gain, p < 0.02) and lumen area to 3.76 ± 0.63 mm2 (16.7%
gain, p < 0.01). When compared to the reference segment lumen area. the
lesional %Iumen area reduction improved from 38.14 ± 16.74% to 25.91 ±
12.17% (p < 0.01). Lumen improvement occurred primarily by expansion of
the total vessel area (12.08 ± 3.01 mm2 to 12.51 ± 3.11 mm2 , p = ns). As
expected, there was a large degree of residual atheroma (68.62 ± 7.47%
cross sectional narrowing). After routine PTCA. only 5 of 12 patients reached
a target MLD of 75% of the reference lumen diameter. Following balloon
upsizing, 8 of 12 had reached this criteria.
Conclusions: ICUS guided balloon upsizing based on the degree of refer·
ence segment disease may be safely performed and results in significant
improvement in luminal cross sectional area above that achieved byangio-
graphic guidance alone. This may potentially lower restenosis rates if these
initial gains are sustained long term.
Javier GOleolea, Lourdes Arganda, Fernando Alfonso, Rosana Hernandez,
Javier Segovia, Adolfo Rodriguez, Carlos Maeaya. Hospital Universitario San Carlos,
Madrid, Spain
Radiofrequency thermal balloon angioplasty (RF) may be performed with
very low balloon pressures, decreasing barotrauma, and a lower incidence
of dissections has been reported. In order to study the mechanism responsi-
ble for dilation after RF. we have imaged with intracoronary ultrasound (ICUS)
[mechanically rotated transducer; 20-30 MHz; 3.5--4.8F], 12 lesions, of a to-
tal of 31 included in a prospective protocol designed to evaluate the use-
fulness of RF. In 11/12 lesions we were able to obtain interpretable images,
and these are the subject of our study. In 9/11 (81 %) of the lesions, imag-
ing was attempted both before (pre). and after (Post) RF and in 2 the ICUS
catheter could not cross the lesion previous to RF. Plaque on IVUS was con-
sidered hypoechogenic (n = 4, 36%). fibrotic (n = 4, 36%) or calcified (n =
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William B. Burns, James B. Hermiller, Katherine B. Kisslo, Stephen C. Culp, Charles
J. Davidson. Northwestern Univ. Chicago, IL; Duke Univ. Durham. NC
Intracoronary ultrasound (ICUS) has detected left main coronary artery
(LMCA) disease that is silent by contrast angiography. The prognostic im-
portance of ICUS detected LMCA disease is unknown. To determine the
long-term outcome of LMCA disease detected by ICUS, long-term clinical
followup was obtained in 30 consecutive patients. ICUS LMCA evaluation
was performed immediately following successful PTCA of the LAD or LCX.
Mean followup was 3 years (range 2--4 yrs). ICUS and quantitative angiog-
raphy were analyzed for predictors of clinical outcome. Angiographically, 21
patients had normal LMCA and 9 were insignificantly abnormal; by ICUS 23
had >20% area stenosis. Major cardiovascular (CV) events occurred in 9, in-
cluding 6 CABG, 2 cardiac deaths and 1 MI. No significant difference in age,
LVEF, number or location of arteries involved were noted between those with
and without events.
40
10
%
Major 20
CV
Event
Conclusions: ICUS may predict cardiovascular prognosis in patients with
angiographically silent LMCA disease. Patients with ICUS determined left
main area stenosis >20% appear to have a higher incidence of major clinical
cardiovascular events at long-term followup.
Braden W. Batkoff, David 1 Linker. University of Washington. Seattle, WA
The clinical use of intracoronary ultrasound (ICUS) is growing, serving as a
useful adjuvant to contrast angiography, and providing additional information
to assist with catheter based interventions. Despite the increasing use of this
technique, it remains an invasive procedure which the safety has not been
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A greater number of adults with CV events were identified in the PFO
group (50) vs control group (34). p < 0.07. The proportion of adults with
The relative odds associated with a 80 mg/dl (1 STD) increase of fibrino-
gen (adjusted in multiple logistic regression for the above parameters) was
1.47 (90% CI1.22-1.77). Conclusion: Fibrinogen emerged as an independent
predictor of strokelTlA in CIHD pts.
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Age PFO Stroke (PFO group) Stroke (Control group)
(yrs) NON CRYP NON CRYP
0-1 520 (26%) 1 a a a
1-18 88(2%) a a 1 a
18-50 127(1%) 9 13 1 a
>50 309(1%) 23 5 28 5
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embolism, non-fatal myocardial infarction or vascular death. An interim anal-
ysis carried out on the first 582 patients irrespectively from treatment groups
showed an overall stroke rate (2.9%) and a frequency of primary end-points
(7.4%) very similar to those observed in the anticoagulant arm of a recently
published study (European Atrial Fibrillation Trial). The final results of the SIFA
trial should help to clarify the role of antiplatelet drugs in the prevention of
stroke in NVAF patients.
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1735-21 Fibrinogen is an Independent Predictor of Ischemic
StrokerrlA in Patients with Coronary Heart Disease
David Tanne, Uri Goldbourt, Michal Benderly, Valentina Boyko,
Henrietta Reicher-Reiss, Solomon Behar, Bezafibrate Infarction Prevention (SIP)
Study Group. Neufeld Cardiac Research Institute, Tel Hashomer, fsrael
In order to determine the association between baseline fibrinogen levels and
subsequent development of ischemic stroke or transient ischemic attack
(TIA) we followed prospectively patients (pts) with chronic ischemic heart
disease (CIHD) included in the BIP study for new cerebrovascular events.
This study includes 31 22 pts aged 45-74 with TC 180-250, triglycerides,
:,:300 and HDL :,:45 mg/dl without a prior stroke, randomized to either 400
mg/dl Bezalip Retard or placebo. The annual rate of cerebrovascular events
among these pts was 0.8% (69 pts - 12 TIA, 57 stroke). Fifty of the strokes
were cerebral infarction, 5 of uncertain type (probably ischemic) and 2 in-
tracerebral hemorrhage. Pts developing ischemic strokelTlA (67 pts) were
older than those without this complication (mean age 61.5 vs. 59.7 years).
had higher systolic blood pressure measurements (138 ± 21 vs. 133 ± 18
mmHg) and higher rate of severe (class 2-4) anginal syndrome (36% vs.
23%). History of diabetes (24% vs. 9%), peripheral vascular disease (10%
vs. 3%) and current smoking (19% vs. 11 %) were more prevalent among pts
with ischemic strokelTlA than among counterparts without this complication
(p < 0.05). Fibrinogen levels were significantly higher in pts subsequently de-
veloping ischemic strokelTlA (388 ± 70 vs. 349 ± 73 mg/dl, p < 0.0001). Age
adjusted ischemic strokelTlA rates/100 person years in fibrinogen quintiles
were as follows.
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Foramen Ovale: Association with Cryptogenic
Cerebrovascular Events in Adults
Sumita D. Paul, Mary Etta King, Michael H. Picard, Stella V. Brili, Peter Lang, John
B. Newell, Richard R. Liberthson, Ariane J. Marelli. Massachusetts General Hospital,
Harvard Medical School, Boston, MA
The natural history of patent foramen ovale (PFO) in association with cere-
brovascular (CV) events has not been described. With the development of
devices for non-surgical closure of atrial septal defect, it is possible that
the risk of PFO closure may be minimal. However, the potential benefit of
PFO closure remains unknown and difficult to assess due lack of adequate
data.
To determine the prevalence of PFO and its association with cryptogenic
(CRYP) and non-cryptogenic (NON) stroke, we examined the database of
37,940 consecutive pts who underwent echocardiography between 1984
to 1994, to identify pts diagnosed with PFO (n = 1044) and designed an
age-matched nested case-control study with 2088 pts to determine the as-
sociation of CV events to PFO. All CV events were confirmed by review of
medical records. NON stroke was defined: cardiogenic, atherosclerotic, la-
cunar, arteritis, aneurysm, hematoma. CRYP stroke was diagnosed by ex-
clusion when the event could not be ascribed to causes in the NON group.
Results: The age distribution is given below:
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Three-dimensional (3-D) vessel reconstruction using intravascular ultrasound
(IVUS) is limited by the lack of information on the real vessel curvatures and
the orientation of the IVUS catheter.
To overcome these limitations a method was developed using data ob-
tained from ANGiography and intravascular UltraSound (ANGUS). This tech-
nique provides real spatial geometry and orientation of coronary lumen and
plaque. The artery is studied by IVUS during a pull-back (PB) of the IVUS
catheter at a speed of 1 mm/s. Start and end of the PB are recorded by bi-
plane fluoroscopy (BF) and finally biplane coronary angiography (BA) is per-
formed without changes in geometrical X-ray settings.
Using a new computer program the contours of the lumen-plaque and
plaque-adventit;a boundaries are semi-automatically detected at 0.5 mm
intervals. BF allows geometrical reconstruction of the catheter trajectory,
which is the path of the IVUS transducer during PB. Combined use of the
IVUS data, the catheter trajectory and the lumen contours in the BA pro-
vides a unique 3-D reconstruction of coronary arteries without any evidence
of an additional unknown geometric factor. Studying the trajectory in a ves-
sel phantom of known dimensions a high accuracy was found (distance be-
tween reconstructed and real trajectory at any point <2 mm). First appli-
cation in a human right coronary artery in-vivo (length: 75 mm) showed a
difference of 2% between the length of the reconstructed trajectory and the
PB distance. Checking the locations of the origin of side-branches in the 3-D
reconstruction and BA differences of less than 2 mm were found. Location
and shape of stenoses in simulated projections of the reconstructed lumen
matched well with BA. However, at the site of a previous PTCA luminal hazi-
ness in angiography and dissection observed by IVUS may slightly reduce
the accuracy of this technique.
Thus combining ANGiography and intravascular UltraSound (ANGUS) is
promising and provides a unique reconstruction of 3-D coronary geometry.
Camelis J. Slager, Martin Laban, Clemens von Birgelen, Rob Krams, Jan
A.F. Oomen, Ad den Boer, Li Wenguang, Pim J. de Feyter, Patrick W Serruys. Jos
R.T.C. Roeland!. Thoraxcenter, Erasmus University Rotterdam, The Netherlands
ANGUS: A New Approach to Three-dimensional
Reconstruction of Geometry and Orientation of
Coronary Lumen and Plaque by Combined Use of
Coronary Angiography and IVUS
3, 28%). In all cases except in 1, in which balloon PTCA was used after RF,
RF was used alone. Pressure was maintained at the lowest level to assure
full balloon expansion, temperature was set to 55'C. After RF lumen area
increased from 2.3 ± 1.1 mm2 to 7.19 ± 1.8 mm2 (p < 0.001). After RF in 7
lesions (63%) plaque rupture was observed (1 partial; 2 extending to media;
4 with accompanying dissection). The main mechanism for the increase in
lumen area was: a) Plaque rupture and/or dissection n = 6 (54%); b) Plaque
compression n = 4 (36%); c) "Total artery" dilation n = 1 (9%).
In conclusion, the mechanism of luminal enlargement after RF, as viewed
with ICUS, was similar to that reported with conventional PTCA, with plaque
rupture/dissection followed by plaque compression being the main mecha-
nisms.
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Gabriella Cataldo, SIFA Study Group. Institute of Neurology, University of Rome "La
Sapienza~ Italy
The effect of oral anticoagulation for primary and secondary prevention of
stroke in patients with non-valvular atrial fibrillation (NVAF) has been clearly
shown in several studies. Still uncertain is the role of antiplatelet agents. The
SIFA is a multicenter open randomized trial which aims to compare the effi-
cacy and safety of an oral anticoagulant treatment (Wartarin to obtain an INR
of 2.0-3.5) with an antiplatelet drug (Indobufen, a reversible cyclooxygenase
inhibitor, 100-200 mg bid) in patients with NVAF and a recent (:,:14 days)
transient ischaemic attack or stroke. The study started in January 1991 and
is expected to be completed by December 1994. Nine hundred and fifty pa-
tients entered the trial and were treated for 12 months. The primary outcome
events were: non-fatal stroke (including cerebral haemorrhage), systemic
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